Evidence map›Paper›PMID 40846769›Full record

ArticleNpj mental health research2025

Real-world effectiveness of a widely available digital health program in adults reporting a lifetime diagnosis of ADHD.

Allen M Osman, Kevin P Madore, Paul I Jaffe, Emanuela Offidani, Ann C Childress, Jeffrey H Newcorn, Robert J Schafer

Abstract read
In one paragraph

Article in Npj mental health research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Allen M OsmanDepartment of Research and Development, Lumos Labs, San Francisco, CA, USA. research@lumoslabs.com.
Kevin P MadoreDepartment of Research and Development, Lumos Labs, San Francisco, CA, USA.
Paul I JaffeDepartment of Psychology, Stanford University, Stanford, CA, USA.
Emanuela OffidaniDepartment of Research and Development, Lumos Labs, San Francisco, CA, USA.
Ann C ChildressCenter for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV, USA.
Jeffrey H NewcornDepartment of Psychiatry and Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Robert J SchaferDepartment of Research and Development, Lumos Labs, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined real-world evidence on whether Lumosity, a remote digital health technology designed to deliver cognitive training to healthy adults, can improve cognition and reduce inattention in adults who reported having received a prior (lifetime) diagnosis of ADHD. Over the course of Lumosity training, this cohort of commercial users was assessed repeatedly online with a neuropsychological test battery (NCPT) and a scale of attention and mood in real-world contexts (BAMS-7). More Lumosity training between successive assessments led to greater improvements on the NCPT composite measure and the attentional subscale of the BAMS-7. This positive dose-response relation was found for six of eight NCPT subtests and three of four BAMS-7 attentional items. Additional findings support the participants' clinical status and sensitivity of the assessments to ADHD symptoms. These findings provide evidence of cognitive and attentional benefits in a real-world cohort of adults reporting a lifetime diagnosis of ADHD from training with Lumosity under real-world conditions.

Identifiers

PMID40846769
PMCPMC12373820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.